Actinium Pharmaceuticals News - ATNM

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Actinium Pharmaceuticals Inc ATNM AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0119 5.95% 0.212 0.2149 0.199 0.199 0.2001 20:00:00
more quote information »

Recent News

Date Time Source Heading
8/09/201917:03EDGARQuarterly Report (10-q)
7/16/201917:19EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201917:14EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201917:11EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201917:07EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201917:03EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201916:59EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201916:59EDGARStatement of Changes in Beneficial Ownership (4)
7/16/201916:56EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201917:05EDGARCurrent Report Filing (8-k)
5/10/201916:58EDGARQuarterly Report (10-q)
5/10/201916:51EDGARSecurities Registration: Employee Benefit Plan (s-8)
4/18/201917:25EDGARCurrent Report Filing (8-k)
4/18/201917:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/18/201911:52EDGARStatement of Ownership (sc 13g)
4/17/201916:18EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/15/201917:05EDGARAnnual Report (10-k)
3/12/201917:26EDGARCurrent Report Filing (8-k)
3/07/201916:52EDGARStatement of Changes in Beneficial Ownership (4)
2/21/201916:48EDGARStatement of Changes in Beneficial Ownership (4)
2/14/201914:20EDGARAmended Statement of Ownership (sc 13g/a)
2/05/201908:00PRNUSActinium Initiates Novel Phase 1/2 Combination Trial of..
2/04/201908:00PRNUSActinium Initiates Second Dosing Cohort of Novel Combination..
1/29/201908:00PRNUSActinium Pharmaceuticals to Host Key Opinion Leader..
1/25/201908:00PRNUSActinium Pharmaceuticals, Inc. to Present at Noble Capital..
1/23/201908:00PRNUSActinium Pharmaceuticals Appoints Accomplished Industry..
1/17/201908:00PRNUSActinium Successfully Completes First Module of..
1/16/201908:00PRNUSActinium Pharmaceuticals Appoints Qing Liang, PhD, DABR as..
1/03/201908:00PRNUSActinium Pharmaceuticals, Inc. to Present at the 2019..
12/28/201817:11EDGARCurrent Report Filing (8-k)
12/28/201817:10EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/26/201817:03EDGARCurrent Report Filing (8-k)
12/21/201816:59EDGARCurrent Report Filing (8-k)
12/10/201816:15EDGARStatement of Changes in Beneficial Ownership (4)
12/10/201816:12EDGARStatement of Changes in Beneficial Ownership (4)
12/04/201808:00PRNUSActinium Pharmaceuticals Highlights Analysis of Pivotal..
12/03/201808:00PRNUSActinium Highlights Actimab-A Phase 2 Trial Results in Older..
11/20/201817:10EDGARStatement of Changes in Beneficial Ownership (4)
11/19/201808:00PRNUSActinium Pharmaceuticals, Inc. to Present at 30th Annual..
11/16/201817:02EDGARProxy Statement (definitive) (def 14a)
11/09/201817:05EDGARQuarterly Report (10-q)
11/05/201808:00PRNUSActinium Pharmaceuticals to Present at BIO-Europe® 24th..
11/01/201809:01PRNUSActinium Pharmaceuticals ASH Annual Meeting Presence to..
10/30/201817:08EDGARProxy Statement - Notice of Shareholders Meeting..
10/30/201817:05PRNUSActinium Pharmaceuticals CD33 Program to Focus on..
10/26/201808:00PRNUSActinium Pharmaceuticals to Hold Webinar Showcasing..
10/24/201808:00PRNUSActinium Pharmaceuticals Announces Participation at..
10/22/201808:04PRNUSActinium Pharmaceuticals Announces Webinar Showcasing..
See more news about this stock »


Your Recent History
AMEX
ATNM
Actinium P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.